Lv1
8 积分 2025-08-30 加入
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
1个月前
已完结
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer
1个月前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
2个月前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
2个月前
已完结
Nivolumab plus Ipilimumab in MicrosatelliteInstability–High Metastatic Colorectal Cancer
2个月前
已完结
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
2个月前
已完结
Cetuximab for the treatment of colorectal cancer
3个月前
已完结
Cetuximab for the treatment of colorectal cancer
3个月前
已关闭
Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
5个月前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
